000120178 001__ 120178
000120178 005__ 20240319081014.0
000120178 0247_ $$2doi$$a10.3389/ijph.2022.1604913
000120178 0248_ $$2sideral$$a130610
000120178 037__ $$aART-2022-130610
000120178 041__ $$aeng
000120178 100__ $$aLear-Claveras, Ana
000120178 245__ $$aSex Differences in Clinical Parameters, Pharmacological and Health-Resource Utilization in a Population With Hypertension Without a Diagnosis of COVID-19
000120178 260__ $$c2022
000120178 5060_ $$aAccess copy available to the general public$$fUnrestricted
000120178 5203_ $$aObjectives: Determine the changes in clinical, pharmacological and healthcare resource use parameters, between the 6 months prior to the lockdown and the 6 months following its end, in a population with hypertension who did not have a diagnosis of COVID-19.Methods: Real world data observational study of 245,979 persons aged >16 years with hypertension in Aragon (Spain). Clinical (systolic-diastolic blood pressure, estimated glomerular filtration rate (eGFR), blood creatinine, cholesterol, triglycerides and anthropometric measures); pharmacological (diuretics, calcium channel antagonists, and ACE inhibitors); and utilization of healthcare resources were considered. We performed the Student’s T-test for matched samples (quantitative) and the Chi-squared test (qualitative) to analyze differences between periods.Results: SBP, DBP, parameters of renal function and triglycerides displayed a significant, albeit clinically irrelevant, worsening in women. In men only DBP and eGFR showed a worsening, although to a lesser extent than in women. Certain antihypertensive drugs and health-resource utilization remained below pre-pandemic levels across the 6 months post-lockdown.Conclusion: Changes in lifestyles, along with difficulties in access to routine care has not substantially compromised the health and quality of life of patients with hypertension.
000120178 536__ $$9info:eu-repo/grantAgreement/ES/ISCIII-RICAPPS/RD21-0016-0005$$9info:eu-repo/grantAgreement/ES/ISCIII-RICAPPS/RD21-0022
000120178 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000120178 590__ $$a4.6$$b2022
000120178 592__ $$a1.289$$b2022
000120178 591__ $$aPUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH$$b42 / 180 = 0.233$$c2022$$dQ1$$eT1
000120178 593__ $$aPublic Health, Environmental and Occupational Health$$c2022$$dQ1
000120178 591__ $$aPUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH$$b64 / 207 = 0.309$$c2022$$dQ2$$eT1
000120178 593__ $$aHealth (social science)$$c2022$$dQ1
000120178 594__ $$a5.0$$b2022
000120178 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000120178 700__ $$0(orcid)0000-0001-6565-9699$$aOliván-Blázquez, Bárbara$$uUniversidad de Zaragoza
000120178 700__ $$aClavería, Ana
000120178 700__ $$aCouso-Viana, Sabela
000120178 700__ $$aPuente-Comesaña, Jesús
000120178 700__ $$0(orcid)0000-0002-5494-6550$$aMagallón Botaya, Rosa$$uUniversidad de Zaragoza
000120178 7102_ $$14009$$2740$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicología Social
000120178 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000120178 773__ $$g67 (2022), 1604913 [10 pp.]$$pInt. j. public health$$tInternational Journal of Public Health$$x1661-8556
000120178 8564_ $$s643482$$uhttps://zaguan.unizar.es/record/120178/files/texto_completo.pdf$$yVersión publicada
000120178 8564_ $$s2022667$$uhttps://zaguan.unizar.es/record/120178/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000120178 909CO $$ooai:zaguan.unizar.es:120178$$particulos$$pdriver
000120178 951__ $$a2024-03-18-15:25:18
000120178 980__ $$aARTICLE